BCL2L11 and neoplasm: Simultaneous inhibition of glycolytic ATP production and increased ROS generation by elevated BIM levels may render tumor cells, often showing a more glycolytic phenotype, increasingly dependent on mitochondrial oxidative phosphorylation, and thus more susceptible to mitotoxicants.